NCT06888258 Compare Analgesia Between MTP Block And ESPB in MRM
| NCT ID | NCT06888258 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Egypt |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-10-01 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is conducted to compare the analgesic efficacy between ultrasound guided Erector Spinae Plane block Vs midpoint transverse process to Pleura block in modified radical mastectomy surgeries
Eligibility Criteria
Inclusion Criteria: * ASA I-II. * Undergoing modified radical mastectomy surgery. * Body mass index (BMI) from 18.5 to 30 kg/m2 Exclusion Criteria: * Patient refusal. * Known allergy to local anesthetics. * Bleeding disorders; platelets count \<50,000 , prothrombin concentration \< 60% or any coagulopathy disorder. * Use of any anti-coagulants. * Inability to provide informed consent. * ASA III-IV. * Neurological disorders. * Patient with psychiatric disorders
Contact & Investigator
Maie Kamal El-Din Helaly, MD
STUDY DIRECTOR
National cancer institute, Cairo University
Frequently Asked Questions
Who can join the NCT06888258 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06888258 currently recruiting?
Yes, NCT06888258 is actively recruiting participants. Contact the research team at doc.mahmoudsaad@gmail.com for enrollment information.
Where is the NCT06888258 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06888258 clinical trial?
NCT06888258 is sponsored by National Cancer Institute, Egypt. The principal investigator is Maie Kamal El-Din Helaly, MD at National cancer institute, Cairo University. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.